MTOX Financial Facts

Clinical trial services: 2.15M
Basic (in shares): 8.9M
See Full Income Statement

Treasury stock, at cost, 103,460 shares in 2011 and 2010: -1.01M
Accumulated deficit: -12.72M
See Full Balance Sheet

MEDTOX Scientific (MTOX) Earnings

  |   Expand Research on MTOX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -5.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
7/11/12 Q212 $0.14$0.21 -$0.07$30M$30.28M N/A +0.3% Details
10/13/11 Q311 $0.15$0.17 -$0.02$27.6M$28.58M N/A +96.5% Details
7/14/11 Q211 $0.16$0.18 -$0.02$27.9M$28.12M N/A +54.6% Details
4/12/12 Q112 $0.17$0.13 +$0.04$28.6M$27.42M N/A +51.3% Details
2/9/12 Q411 $0.11$0.12 -$0.01$26.9M$26.88M N/A +61.4% Details
4/14/11 Q111 $0.09$0.08 +$0.01$25.7M$24.5M N/A +72.6% Details
2/10/11 Q410 $0.09$0.09 $0.00$25M$24.49M N/A +75.6% Details
10/13/10 Q310 $0.13$0.13 $0.00N/AN/A N/A +129.6% Details